Naderin

Preclinical

MMIPO Clinic

Naderin is one of 36 therapeutic programs targeting Breast Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Breast CancerCompleted

Malignant NeoplasmCompleted

Breast CancerPreclinical

Completed

Malignant NeoplasmPreclinical

Completed

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Cymbalta

Alnylam Pharmaceuticals

Preclinical

3 2

MS Contin

Merck & Co.

Preclinical

2 3

Blenoxane

Bristol-Myers Squibb

Preclinical

1 4

Effexor

WWyeth-Lederle Vaccines

Preclinical

2 5

Cortef

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

1 6

Zoladex

Luye Pharma Group Ltd.

Preclinical

8 7

Neoadjuvant Therapy

SSun Yat-sen University

Preclinical

3 8

Fentanyl Citrate

IINSYS Therapeutics Inc

Preclinical

2 9

Diuretic

RReprieve Cardiovascular, Inc

Preclinical

1 10

Metfomin

UUniversity of Texas Southwestern Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Breast Cancer1 trial

Medical Rehabilitation in Oncology: Prophylaxis of Hematologic and Immunologic Complications Using Naderin During First-Line Chemotherapy of Breast Cancer

Completed·MMIPO Clinic·Preclinical·NCT07671547·79 enrolled

Malignant Neoplasm1 trial

Prophylaxis of Complications of Basic Therapy and Medical Rehabilitation Using Naderin in Socially Significant Diseases, Including Malignant Neoplasms, Tuberculosis, and Hepatitis C

Completed·MMIPO Clinic·Preclinical·NCT07671508·75 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Naderin. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Naderin. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — MIPO Clinic company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: MMIPO Clinic

Naderin

Status by Indication[2][1]

Competitive Landscape

Trials by Indication[1]

Breast Cancer1 trial

Malignant Neoplasm1 trial

References

Drug Info

Quick Facts

Related News